Zanidatamab
Zymeworks,Jazz
['zanida', 'zanidatamab']
her2-targeted bispecific antibody zanidatamab demonstrated durable responses in patients with treatment-refractory her2-positive biliary tract cancer, researchers from the university of texas md anderson cancer center reported at #asco23. 
Reporting essential clinical news w/ independent analysis for cancer care professionals to optimize patient care & outcomes; oncology/hematology